XML 64 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Incentive Plans - Summary of Activity for Service-based Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Aggregate Intrinsic Value $ 1,393,000 $ 22,512,000  
2022 Inducement Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of Options and Unvested Shares, exercised 0    
Aggregate Intrinsic Value $ 0    
Novosteo      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Aggregate Intrinsic Value $ 0 $ 0  
Service Based Stock Options | 2019 Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of Options and Unvested Shares, beginning balance 5,571,293 4,790,327  
Number of Options and Unvested Shares, granted 2,051,058 1,436,116  
Number of Options and Unvested Shares, exercised (102,152) (531,190)  
Number of Options and Unvested Shares, Options cancelled / forfeited (4,200,488) (123,960)  
Number of Options and Unvested Shares, ending balance 3,319,711 5,571,293 4,790,327
Number of Options and Unvested Shares, vested and expected to vest 3,319,711    
Number of Options and Unvested Shares, exercisable 2,209,330    
Weighted Average Exercise Price, beginning balance $ 28.70 $ 25.47  
Weighted Average Exercise Price, granted 8.13 35.20  
Weighted Average Exercise Price, exercised 1.45 12.82  
Weighted Average Exercise Price, cancelled/forfeited 29.30 47.09  
Weighted Average Exercise Price, ending balance 16.07 $ 28.70 $ 25.47
Weighted Average Exercise Price, vested and expected to vest 16.07    
Weighted Average Exercise Price, exercisable $ 20.13    
Weighted Average Remaining Contractual Life 4 years 9 months 7 days 8 years 3 months 3 days 8 years 8 months 8 days
Weighted Average Remaining Contractual Life, vested and expected to vest 4 years 9 months 7 days    
Weighted Average Remaining Contractual Life, exercisable 2 years 6 months 7 days    
Aggregate Intrinsic Value $ 65,000 $ 15,687,000 $ 49,723,000
Aggregate Intrinsic Value, vested and expected to vest 65,000    
Aggregate Intrinsic Value, exercisable $ 65,000    
Service Based Stock Options | 2022 Inducement Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of Options and Unvested Shares, granted 3,744,255    
Number of Options and Unvested Shares, Options cancelled / forfeited (2,000)    
Number of Options and Unvested Shares, ending balance 3,742,255    
Number of Options and Unvested Shares, vested and expected to vest 3,742,255    
Weighted Average Exercise Price, granted   $ 2.98  
Weighted Average Exercise Price, cancelled/forfeited $ 2.98    
Weighted Average Exercise Price, ending balance 2.98    
Weighted Average Exercise Price, vested and expected to vest $ 2.98    
Weighted Average Remaining Contractual Life 9 years 4 months 20 days    
Weighted Average Remaining Contractual Life, vested and expected to vest 9 years 4 months 20 days    
Service Based Stock Options | Novosteo      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of Options and Unvested Shares, assumed 507,648    
Number of Options and Unvested Shares, Options cancelled / forfeited (4,543)    
Number of Options and Unvested Shares, ending balance 503,105    
Number of Options and Unvested Shares, vested and expected to vest 503,105    
Weighted Average Exercise Price, assumed $ 0.55    
Weighted Average Exercise Price, cancelled/forfeited 0.55    
Weighted Average Exercise Price, ending balance 0.55    
Weighted Average Exercise Price, vested and expected to vest $ 0.55    
Weighted Average Remaining Contractual Life 9 years 2 months 23 days    
Weighted Average Remaining Contractual Life, vested and expected to vest 9 years 2 months 23 days    
Aggregate Intrinsic Value $ 44,000    
Aggregate Intrinsic Value, vested and expected to vest $ 44,000